Proficio Capital Partners LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1654175
NEWTON, MA
Position in ALNY
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$276,646
+$54,118 QoQ
Shares Held
919
+88.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#555
of 784 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Proficio Capital Partners LLC holds $4,501,972 across 8 Biotechnology names. ALNY ranks #7 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KYMR |
Kymera Therapeutics, Inc.
|
11,045 | $1,266,530 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,184 | $1,084,858 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
909 | $566,797 | |
| 4 | INCY |
Incyte Corp
|
4,483 | $508,192 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
1,786 | $430,372 | |
| 6 | MRNA |
Moderna, Inc.
|
4,251 | $297,697 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
919 | $276,646 | |
| 8 | FATE |
Fate Therapeutics Inc
|
26,252 | $70,880 |
All Filings in ALNY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $276,646 | 919 | Shares | Sole | 2026-08-17 | |
| 2025-09-30 | $222,528 | 488 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $287,611 | 882 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $218,176 | 808 | Shares | Sole | 2025-05-06 | |
| 2024-09-30 | $204,622 | 744 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $384,426 | 1,582 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $305,774 | 2,046 | Shares | Sole | 2024-05-02 | |
| No filing history on record for this holder in this stock. | ||||||